NCT05686733View on ClinicalTrials.gov

Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

February 17, 2024

Study Completion Date

February 17, 2024

Conditions
Aneurysms SaccularAneurysm, RupturedAneurysm
Interventions
DEVICE

SEAL Device

Endovascular treatment of target aneurysm using the Saccular Endovascular Aneurysm Lattice (SEAL) device.

Trial Locations (1)

Unknown

Clinicas Las Americas, Medellín

Sponsors
All Listed Sponsors
lead

Galaxy Therapeutics INC

INDUSTRY